Jesper Bøje Andersen
Biotech Research & Innovation Centre, University of Copenhagen
Jesper B Andersen received his Ph.D. in molecular and cellular biology from the University of Aarhus. His doctoral dissertation described the role of two interferon-stimulated genes, i.e., ISG15 and RNase-L in cancer, and was conducted under the joint mentorship of Dr. Bret A. Hassel, University of Maryland Baltimore, Marlene & Stewart Greenebaum Cancer Center in Baltimore USA and Dr. Just Justesen at the University of Aarhus, Denmark. Dr. Andersen joined the laboratory of Dr. Snorri S Thorgeirsson (Laboratory of Experimental Carcinogenesis) at the National Cancer Institute (NCI), NIH in Bethesda USA in 2007 as a Research Fellow where his research has involved several genomic and epigenomic aspects of hepatocarcinogenesis. At the NCI, Jesper focused his research on the systematic characterization of cholangiocarcinoma (CCA), a lethal and treatment refractory subtype of liver cancer of the biliary tree. Using cutting-edge translational genomics, e.g., single-cell genomics, he is studying tumor heterogeneity. In 2014, Jesper was appointed Group leader at BRIC.